Clinical Trial Update: An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating a regimen of docetaxel with high-dose 5-fluorouracil and leucovorin (HDFL) for inoperable advanced or metastatic gastric cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN